Red Spruce Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Red Spruce Capital's MDT Position: Q3 2026 in Review
Red Spruce Capital sold out of Medtronic (MDT) in Q3 2026, closing a stake of 25,799 shares — an estimated $2.02M sold.
Red Spruce Capital first reported a position in MDT in Q4 2019 and held it in 27 quarters. The position peaked at $2.3M in Q4 2025. 917 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Red Spruce Capital reported no remaining Medtronic position as of Q3 2026 after selling out during the quarter.
- Red Spruce Capital sold 25,799 Medtronic shares in Q3 2026, an estimated $2.02M.
- Red Spruce Capital first reported a position in Medtronic in Q4 2019 and held it in 27 quarters.
- Red Spruce Capital's Medtronic position peaked at $2.3M in Q4 2025.
- 917 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Red Spruce Capital's 13F filing for Q3 2026, filed 7 Oct 2026.